In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. I. Kinetics and specificity of the reaction. Influence of metabolic inhibitors and anti-lymphocyte serum.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D002455:Cell Division; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D005347:Fibroblasts / Q000276:immunology; D005838:Genotype; D006648:Histocompatibility; D006801:Humans; D007519:Isoantigens; D007700:Kinetics; D008214:Lymphocytes / Q000276:immunology*; D008775:Methylprednisolone / Q000494:pharmacology*; D008937:Mitomycins / Q000494:pharmacology; D016038:Skin Transplantation; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D000961:Antilymphocyte Serum; D007519:Isoantigens; D008937:Mitomycins; D003609:Dactinomycin; D004247:DNA; D008775:Methylprednisolone